161 related articles for article (PubMed ID: 28813465)
1. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
Yang JH; Li XY; Wang X; Hou WJ; Qiu XS; Wang EH; Wu GP
PLoS One; 2017; 12(8):e0182775. PubMed ID: 28813465
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus 16 (HPV 16) E6 but not E7 inhibits the antitumor activity of LKB1 in lung cancer cells by downregulating the expression of KIF7.
Hu Y; Wu MZ; Gu NJ; Xu HT; Li QC; Wu GP
Thorac Cancer; 2020 Nov; 11(11):3175-3180. PubMed ID: 32945133
[TBL] [Abstract][Full Text] [Related]
4. HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.
Shao JS; Sun J; Wang S; Chung K; Du JT; Wang J; Qiu XS; Wang EH; Wu GP
Tumour Biol; 2017 Jul; 39(7):1010428317717137. PubMed ID: 28720067
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Oh ST; Kyo S; Laimins LA
J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
[TBL] [Abstract][Full Text] [Related]
7. HPV16 E6/E7 upregulate hTERC mRNA and gene amplification levels by relieving the effect of LKB1 on Sp1 phosphorylation in lung cancer cells.
Yang JH; Wu MZ; Wang XB; Wang S; Qiu XS; Wang EH; Wu GP
Ther Adv Med Oncol; 2020; 12():1758835920917562. PubMed ID: 32499837
[TBL] [Abstract][Full Text] [Related]
8. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
Katzenellenbogen RA; Egelkrout EM; Vliet-Gregg P; Gewin LC; Gafken PR; Galloway DA
J Virol; 2007 Apr; 81(8):3786-96. PubMed ID: 17267499
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
11. HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.
James MA; Lee JH; Klingelhutz AJ
Int J Cancer; 2006 Oct; 119(8):1878-85. PubMed ID: 16708385
[TBL] [Abstract][Full Text] [Related]
12. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
13. An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.
Xu M; Katzenellenbogen RA; Grandori C; Galloway DA
Virology; 2013 Nov; 446(1-2):17-24. PubMed ID: 24074563
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.
Gewin L; Myers H; Kiyono T; Galloway DA
Genes Dev; 2004 Sep; 18(18):2269-82. PubMed ID: 15371341
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein.
Veldman T; Horikawa I; Barrett JC; Schlegel R
J Virol; 2001 May; 75(9):4467-72. PubMed ID: 11287602
[TBL] [Abstract][Full Text] [Related]
17. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
[TBL] [Abstract][Full Text] [Related]
18. NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2009 Jul; 83(13):6446-56. PubMed ID: 19369336
[TBL] [Abstract][Full Text] [Related]
19. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
20. Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1.
Liang X; Li ZL; Jiang LL; Guo QQ; Liu MJ; Nan KJ
Int J Oncol; 2014 Jun; 44(6):1989-97. PubMed ID: 24647869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
